BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31453359)

  • 1. Health Utility Book (HUB)-Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer.
    Zoratti MJ; Zhou T; Chan K; Levine O; Krahn M; Husereau D; Clifford T; Schunemann H; Guyatt G; Xie F
    MDM Policy Pract; 2019; 4(2):2381468319852594. PubMed ID: 31453359
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB).
    Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G
    Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health state utility values among children and adolescents with disabilities: protocol for a systematic review.
    Kanya L; Anokye N; Ryan JM
    BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.
    Nerich V; Saing S; Gamper EM; Holzner B; Pivot X; Viney R; Kemmler G
    Breast Cancer Res Treat; 2017 Aug; 164(3):527-536. PubMed ID: 28497177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analyses of drug therapies in breast cancer: a systematic review.
    Nerich V; Saing S; Gamper EM; Kemmler G; Daval F; Pivot X; Holzner B
    Breast Cancer Res Treat; 2016 Oct; 159(3):407-24. PubMed ID: 27572551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.
    Han R; François C; Toumi M
    Appl Health Econ Health Policy; 2021 Jan; 19(1):29-44. PubMed ID: 32661846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review.
    Paracha N; Thuresson PO; Moreno SG; MacGilchrist KS
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):549-559. PubMed ID: 27574879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review.
    Carter GC; King DT; Hess LM; Mitchell SA; Taipale KL; Kiiskinen U; Rajan N; Novick D; Liepa AM
    J Med Econ; 2015; 18(11):954-66. PubMed ID: 26212479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health State Utility Values in Schizophrenia: A Systematic Review and Meta-Analysis.
    Aceituno D; Pennington M; Iruretagoyena B; Prina AM; McCrone P
    Value Health; 2020 Sep; 23(9):1256-1267. PubMed ID: 32940244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of health state utility values for acute myeloid leukemia.
    Forsythe A; Brandt PS; Dolph M; Patel S; Rabe APJ; Tremblay G
    Clinicoecon Outcomes Res; 2018; 10():83-92. PubMed ID: 29416365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can cost utility evaluations inform decision making about interventions for low back pain?
    Dagenais S; Roffey DM; Wai EK; Haldeman S; Caro J
    Spine J; 2009 Nov; 9(11):944-57. PubMed ID: 19748833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature Review.
    Jovanoski N; Abogunrin S; Di Maio D; Belleli R; Hudson P; Bhadti S; Jones LG
    Pharmacoecon Open; 2023 Sep; 7(5):723-738. PubMed ID: 37289325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in oncology drug reimbursement submissions in Canada: A review of submissions to the pan-Canadian Oncology Drug Review.
    Raymakers AJN; Regier DA; Peacock SJ
    Cancer; 2020 Jan; 126(1):148-155. PubMed ID: 31544234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of classic utilities to published pediatric cost-utility studies.
    Finnell SM; Carroll AE; Downs SM
    Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis.
    Muchadeyi MT; Hernandez-Villafuerte K; Schlander M
    BMC Med Res Methodol; 2022 Nov; 22(1):303. PubMed ID: 36434521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health state utility values by cancer stage: a systematic literature review.
    Pourrahmat MM; Kim A; Kansal AR; Hux M; Pushkarna D; Fazeli MS; Chung KC
    Eur J Health Econ; 2021 Nov; 22(8):1275-1288. PubMed ID: 34125315
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.